#151788

Anti-CD19 [LC-1/32/A10]

Cat. #151788

Anti-CD19 [LC-1/32/A10]

Cat. #: 151788

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD19

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CD19 [LC-1/32/A10]
  • Alternate name: CD19 Molecule; B-Lymphocyte Surface Antigen B4; T-Cell Surface Antigen Leu-12; Differentiation Antigen CD19; CD19 Antigen; CVID3; B4
  • Clone: LC-1/32/A10
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB
  • Description: CD19 is a cell surface molecule expressed on B lymphocytes and follicular dendritic cells. It is expressed by most pre-B cells and by the majority of non-T-cell acute lymphocytic leukaemias and B-cell type chronic lymphocytic leukaemias. CD19 assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
  • Immunogen: A synthetic peptide, corresponding to the C-Terminus of CD19.
  • Isotype: IgG1 kappa
  • Myeloma used: NS0
  • Recommended controls: Any human lymphoid tissue or Ramos cell line for CD19 positive and Jurkat for CD19 negative.

Target Details

  • Target: CD19
  • Tissue cell line specificity: Any human lymphoid tissue or Ramos cell line for CD19 positive and Jurkat for CD19 negative.
  • Target background: CD19 is a cell surface molecule expressed on B lymphocytes and follicular dendritic cells. It is expressed by most pre-B cells and by the majority of non-T-cell acute lymphocytic leukaemias and B-cell type chronic lymphocytic leukaemias. CD19 assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Shipping at 4° C

References

  • Carter et al. 1992. Science. 256(5053):105-7. PMID: 1373518.
  • CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.
  • Tedder et al. 1989. J Immunol. 143(2):712-7. PMID: 2472450.
  • Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily.